Human NRIP1 adenoviral particles

Nuclear receptor interacting protein 1 (NRIP1), also known as RIP140, is a multifunctional transcriptional coregulator that plays a key role in regulating the activity of nuclear receptors and other transcription factors. NRIP1 is involved in a variety of physiological processes, including metabolism, reproduction, and immune responses. It acts as a scaffold protein that interacts with ligand-bound nuclear receptors such as estrogen receptor (ER), peroxisome proliferator-activated receptor (PPAR), and thyroid hormone receptor (TR) to fine-tune gene expression. Studies have shown that NRIP1 can inhibit or enhance transcriptional activity depending on the cellular context, making it a key player in maintaining metabolic homeostasis and cell differentiation. NRIP1 dysregulation has been associated with metabolic disorders, cancer, and inflammatory diseases, highlighting its importance as a research target.

Human NRIP1 adenoviral particles are genetically engineered viral vectors designed to efficiently transduce the NRIP1 gene into mammalian cells for functional studies. These particles are based on a replication-defective adenovirus, which ensures high transduction efficiency in a variety of cell types, including primary cells and cells that are difficult to transfect. This adenoviral system can stably and continuously express NRIP1, allowing researchers to study its role in signaling pathways, gene regulation, and disease mechanisms. Human NRIP1 adenoviral particles are widely used in gain-of-function experiments, high-throughput screening, and therapeutic exploration, providing a powerful tool for elucidating the biological functions of NRIP1 and its potential applications in gene therapy and metabolic research.